FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissu...(above organization bySend2Press(R) a uni...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
Date:7/9/2008
above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com
'/>"/>
| SOURCE Epeius Biotechnologies Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. US FDA Grants Pediatric Exclusivity for UCBs Keppra(R)
2. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
3. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
4. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
5. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
6. Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
7. European Union, State of Brandenburg, Award Grants to Alcat Europe, GmbH
8. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
9. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
10. United States Patent Office Grants CryoCors Request for Patent Interference
11. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
Post Your Comments:
Breaking Biology Technology:China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
[0] China Biologic Products to Ring NASDAQ Opening Bell[0] Lotus Pharmaceuticals, Inc. Appoints OTC Division Head[0] Martek Signs Sole-Source Supply Agreement with Fonterra[0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
Other Biology Technology:Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 2Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation 3ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 2ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis 3
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5New discoveries could improve climate projections 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 1Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 3JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 1JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 2JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 3Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 1Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 2Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 3
Other Biology News:Researchers develop new ultrasensitive assay to detect most poisonous substance known 2Early treatment of stomach infection may prevent cancer 2Early treatment of stomach infection may prevent cancer 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 2US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 3US Patent Office rejects company's claim for bean commonly grown by Latin American farmers 4
Biology Products:
Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from AbcamAnti-Human C5a / C5a des-Arg (neo-epitode) Monoclonal Antibody, Unconjugated, Clone 2952 from Cell SciencesFetuin from Equitech-BioAnti-Laminin alpha 2 (Merosin M chain) Monoclonal Antibody, Unconjugated, Clone 5H2 from CHEMICON
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |